References
- Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell124(4), 783–801 (2006).
- Knapp S, Wieland CW, van’t Veer C et al. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J. Immunol.172(5), 3132–3138 (2004).
- Albiger B, Dahlberg S, Sandgren A et al. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell. Microbiol.9(3), 633–644 (2007).
- Malley R, Henneke P, Morse SC et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad. Sci. USA100(4), 1966–1971. (2003).
- Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol.165(10), 5392–5396. (2000).
- Hoebe K, Georgel P, Rutschmann S et al. CD36 is a sensor of diacylglycerides. Nature433(7025), 523–527 (2005).
- Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol.5(10), 975–979 (2004).
- Agnese DM, Calvano JE, Hahm SJ et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J. Infect. Dis.186(10), 1522–1525 (2002).
- Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol.170(7), 3451–3454 (2003).
- Picard C, Puel A, Bonnet M et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science299(5615), 2076–2079 (2003).
- Medvedev AE, Lentschat A, Kuhns DB et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med.198(4), 521–531 (2003).
- Ku C-L, Yang K, Bustamante J et al. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev.203, 10–20 (2005).
- Inohara N, Nunez G. Nods: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol.3(5), 371–382 (2003).
- Franchi L, Amer A, Body-Malapel M et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in Salmonella-infected macrophages. Nat. Immunol.7(6), 576–582 (2006).
- Molofsky AB, Byrne BG, Whitfield NN et al. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med.203(4), 1093–1104 (2006).
- Delbridge LM, O’Riordan MX. Innate recognition of intracellular bacteria. Curr. Opin. Immunol.19(1), 10–16 (2007).
- Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol.7(12), 1250–1257 (2006).
- Ogura Y, Sutterwala FS, Flavell RA. The inflammasome: first line of the immune response to cell stress. Cell126(4), 659–662 (2006).
- Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med.13(5), 552–559 (2007).
- Cornelis S, Kersse K, Festjens N, Lamkanfi M, Vandenabeele P. Inflammatory caspases: targets for novel therapies. Curr. Pharm. Des.13(3), 365–383 (2007).